Alterity Therapeutics Limited (ATHE)
NASDAQ: ATHE · Real-Time Price · USD
3.760
+0.157 (4.36%)
Apr 7, 2026, 4:00 PM EDT - Market closed

Alterity Therapeutics Income Statement

Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
8.847.644.023.925.124.49
Revenue Growth (YoY)
137.32%90.12%2.63%-23.56%14.23%3554.58%
Gross Profit
8.847.644.023.925.124.49
Selling, General & Admin
7.615.484.765.065.516.94
Research & Development
16.5314.418.6413.214.7512.28
Other Operating Expenses
0.380.210.220.330.370.43
Total Operating Expenses
24.5320.123.6318.5920.6319.65
Operating Income
-15.69-12.46-19.61-14.67-15.5-15.16
Interest Income
1.240.450.270.0200.02
Other Non-Operating Income (Expense)
-0.02-0.070.260.92-2.72-0.3
Total Non-Operating Income (Expense)
1.230.380.530.93-2.72-0.28
Pretax Income
-14.46-12.08-19.08-13.7-12.78-15.31
Provision for Income Taxes
-0.13-0.07-0.05-0.1-0.07-
Net Income
-14.59-12.15-19.12-13.81-12.85-15.31
Net Income to Common
-14.59-12.15-19.12-13.81-12.85-15.31
Shares Outstanding (Basic)
15116443
Shares Outstanding (Diluted)
15116443
Shares Change (YoY)
74.72%75.31%50.29%0.91%41.79%89.62%
EPS (Basic)
-0.84-1.14-3.12-3.42-3.18-5.40
EPS (Diluted)
-0.84-1.14-3.12-3.42-3.18-5.40
Shares Outstanding
18.1315.218.744.074.010.35
Free Cash Flow
-10.62-11.45-12.61-20.04-12.43-17.34
Free Cash Flow Per Share
-0.72-1.07-2.07-4.95-3.10-6.13
Gross Margin
100.00%100.00%100.00%100.00%100.00%100.00%
Operating Margin
-177.49%-163.04%-487.82%-374.60%-302.56%-338.10%
Profit Margin
-162.13%-157.19%-473.50%-347.20%-248.01%-341.33%
FCF Margin
-120.15%-149.86%-313.78%-511.78%-242.54%-386.61%
EBITDA
-15.69-12.32-19.46-14.57-15.45-15.09
EBITDA Margin
-177.49%-161.21%-484.15%-371.99%-301.51%-336.42%
EBIT
-15.69-12.46-19.61-14.67-15.5-15.16
EBIT Margin
-177.49%-163.04%-487.82%-374.60%-302.56%-338.10%
Effective Tax Rate
0.90%0.56%0.24%0.76%0.55%0.00%
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q